These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1309403)

  • 1. Evaluation and follow-up of abnormal Pap smears.
    Miller KE; Losh DP; Folley A
    Am Fam Physician; 1992 Jan; 45(1):143-50. PubMed ID: 1309403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Four years of screening cervical smears of cervical lesions].
    Autillo-Touati A; Benmoura D; Palazzi D; Robaglia A; Tasso F; Blanc B; Seite R
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):754-60. PubMed ID: 1469229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive evaluation for atypical squamous cells in Papanicolaou smears.
    Lindheim SR; Smith-Nguyen G
    J Reprod Med; 1990 Oct; 35(10):971-3. PubMed ID: 2246766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'Pap' or cervical smear and the role of colposcopy in screening for carcinoma of the cervix.
    Singh P; Ilancheran A
    Singapore Med J; 1989 Jun; 30(3):302-5. PubMed ID: 2686037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated approach to screening for cervical cancer in older women.
    Celentano DD
    Geriatrics; 1988 Apr; 43(4):37-8, 40-4, 48. PubMed ID: 2832258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cervical smears at King Hussein Medical Centre, Jordan, over three and a half years.
    Malkawi SR; Abu Hazeem RM; Hajjat BM; Hajjiri FK
    East Mediterr Health J; 2004; 10(4-5):676-9. PubMed ID: 16335662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of cervical neoplasia.
    La Vecchia C
    Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
    Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
    Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical signs of HPV infection in PAP-smear negative women with external genital warts.
    Petersen CS; Thomsen HK; Søndergaard J
    Acta Derm Venereol; 1989; 69(5):454-6. PubMed ID: 2572122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study.
    Sun CA; Hsiung CA; Lai CH; Chen CA; Chou CY; Ho CM; Twu NF; Feng WL; Chuang MH; Hsieh CY; Chu TY
    J Med Virol; 2005 Oct; 77(2):273-81. PubMed ID: 16121376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathologic changes associated with intrauterine contraceptive devices. A review of cervico-vaginal smears in 350 women.
    Pillay B; Gregory AR; Subbiah M
    Med J Malaysia; 1994 Mar; 49(1):74-7. PubMed ID: 8057995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital human papilloma virus infection in mentally-institutionalized virgins.
    Shimada T; Miyashita M; Miura S; Nakayama D; Miura K; Fukuda M; Masuzaki H
    Gynecol Oncol; 2007 Sep; 106(3):488-9. PubMed ID: 17532028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.